SynPhNe
SynPhNe develops wearable technology designed to aid neurological rehabilitation for individuals with disabilities, combining brain-computer interface capabilities with wearable health devices to support the recovery process. The technology assists patients in regaining functionality through a system designed for use by both healthcare professionals and patients, enabling remote monitoring and guided rehabilitation…
Funding snapshot
About
SynPhNe develops wearable technology designed to aid neurological rehabilitation for individuals with disabilities, combining brain-computer interface capabilities with wearable health devices to support the recovery process. The technology assists patients in regaining functionality through a system designed for use by both healthcare professionals and patients, enabling remote monitoring and guided rehabilitation exercises. SynPhNe's platform integrates neurological signal processing with wearable sensors to provide real-time feedback on rehabilitation progress, supporting therapy for neurological disorders through brain-computer interface applications in healthcare. The system aims to bridge the gap between clinical rehabilitation sessions and at-home recovery, providing continuous monitoring and adaptive therapy guidance for patients with neurological conditions. Founded in 2011 and headquartered in Singapore, the company has raised approximately $5M in Series A funding. SynPhNe differentiates itself through its combination of brain-computer interface technology with wearable rehabilitation devices, enabling neurological disorder therapy that extends beyond clinical settings into patient-managed recovery with healthcare professional oversight.
Business model
Brain Computer Interface > Applications > Healthcare > Rehabilitation,
Wearable Technology > Health and Wellness Devices > Rehabilitation,
Disease Self Management > Neurological Disorders > Therapy > Rehabilitation > Device > Wearable,
Neurology > Medical Devices > Therapeutic Devices > Stroke Rehabilitation > Physiotheraphy
Founders & team highlights
Serial Founder
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.